Medicine

Quantifying population-level antihypertensive treatment eligibility under the 2025 AHA/ACC hypertension guideline: What has changed — And where the greatest opportunity remains

Huanhuan Yang, Yuan Lu

2026.1.1American Journal of Preventive Cardiology

DOI: 10.1016/j.ajpc.2026.101428

Abstract

Abstract is not available.

Citation format

YANG, Huanhuan; LU, Yuan. Quantifying population-level antihypertensive treatment eligibility under the 2025 AHA/ACC hypertension guideline: What has changed — and where the greatest opportunity remains. American Journal of Preventive Cardiology, 2026, 25: 101428.